Cassandra P. Loren

431 total citations
8 papers, 342 citations indexed

About

Cassandra P. Loren is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Cassandra P. Loren has authored 8 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 3 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Cassandra P. Loren's work include Platelet Disorders and Treatments (6 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Cassandra P. Loren is often cited by papers focused on Platelet Disorders and Treatments (6 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Cassandra P. Loren collaborates with scholars based in United States, France and Singapore. Cassandra P. Loren's co-authors include Owen J. T. McCarty, Joseph E. Aslan, Jiaqing Pang, Garth W. Tormoen, Rachel A. Rigg, Laura D. Healy, András Gruber, Kristina M. Haley, Brian Druker and Asako Itakura and has published in prestigious journals such as Blood, Arteriosclerosis Thrombosis and Vascular Biology and American Journal of Physiology-Cell Physiology.

In The Last Decade

Cassandra P. Loren

8 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cassandra P. Loren United States 7 196 111 96 68 54 8 342
Emiko Maeda Japan 8 269 1.4× 69 0.6× 64 0.7× 83 1.2× 50 0.9× 13 432
Alberto Orfao Spain 13 295 1.5× 118 1.1× 138 1.4× 25 0.4× 126 2.3× 18 444
Hiroshi Nagahisa Japan 10 229 1.2× 122 1.1× 80 0.8× 67 1.0× 45 0.8× 14 401
Brigitte Spath Germany 8 252 1.3× 134 1.2× 83 0.9× 35 0.5× 64 1.2× 14 401
Benoît Guillet France 14 479 2.4× 110 1.0× 146 1.5× 20 0.3× 32 0.6× 46 578
Valentin Ustinov United States 5 210 1.1× 102 0.9× 22 0.2× 73 1.1× 146 2.7× 7 408
Pınar Tarkun Türkiye 9 114 0.6× 126 1.1× 45 0.5× 45 0.7× 44 0.8× 30 309
Alan T. Nurden France 7 197 1.0× 98 0.9× 28 0.3× 47 0.7× 73 1.4× 7 312
Alexandre Guy France 9 143 0.7× 113 1.0× 166 1.7× 22 0.3× 29 0.5× 27 287
Zhifu Xiang United States 7 160 0.8× 176 1.6× 78 0.8× 8 0.1× 79 1.5× 22 355

Countries citing papers authored by Cassandra P. Loren

Since Specialization
Citations

This map shows the geographic impact of Cassandra P. Loren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cassandra P. Loren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cassandra P. Loren more than expected).

Fields of papers citing papers by Cassandra P. Loren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cassandra P. Loren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cassandra P. Loren. The network helps show where Cassandra P. Loren may publish in the future.

Co-authorship network of co-authors of Cassandra P. Loren

This figure shows the co-authorship network connecting the top 25 collaborators of Cassandra P. Loren. A scholar is included among the top collaborators of Cassandra P. Loren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cassandra P. Loren. Cassandra P. Loren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Aslan, Joseph E., Rachel A. Rigg, Cassandra P. Loren, et al.. (2015). Lysine acetyltransfer supports platelet function. Journal of Thrombosis and Haemostasis. 13(10). 1908–1917. 26 indexed citations
2.
Rigg, Rachel A., Joseph E. Aslan, Laura D. Healy, et al.. (2015). Oral administration of Bruton's tyrosine kinase inhibitors impairs GPVI-mediated platelet function. American Journal of Physiology-Cell Physiology. 310(5). C373–C380. 57 indexed citations
3.
Loren, Cassandra P., Joseph E. Aslan, Rachel A. Rigg, et al.. (2014). The BCR-ABL inhibitor ponatinib inhibits platelet immunoreceptor tyrosine-based activation motif (ITAM) signaling, platelet activation and aggregate formation under shear. Thrombosis Research. 135(1). 155–160. 67 indexed citations
4.
Aslan, Joseph E., Asako Itakura, Kristina M. Haley, et al.. (2013). p21 Activated Kinase Signaling Coordinates Glycoprotein Receptor VI–Mediated Platelet Aggregation, Lamellipodia Formation, and Aggregate Stability Under Shear. Arteriosclerosis Thrombosis and Vascular Biology. 33(7). 1544–1551. 34 indexed citations
5.
Aslan, Joseph E., Cassandra P. Loren, Kristina M. Haley, et al.. (2013). The PAK system links Rho GTPase signaling to thrombin-mediated platelet activation. American Journal of Physiology-Cell Physiology. 305(5). C519–C528. 38 indexed citations
6.
Aslan, Joseph E., Cassandra P. Loren, Jiaqing Pang, et al.. (2011). Characterization of the Rac guanine nucleotide exchange factor P-Rex1 in platelets. PubMed. 6. 11–11. 15 indexed citations
7.
Haley, Kristina M., Cassandra P. Loren, Kevin G. Phillips, & Owen J. T. McCarty. (2011). Characterization of Single Platelet Mass, Volume, and Density in Response to Agonist Stimulation. Blood. 118(21). 5261–5261. 3 indexed citations
8.
Aslan, Joseph E., Garth W. Tormoen, Cassandra P. Loren, Jiaqing Pang, & Owen J. T. McCarty. (2011). S6K1 and mTOR regulate Rac1-driven platelet activation and aggregation. Blood. 118(11). 3129–3136. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026